Maternal and Infant Opioid Screening for Neonates at Risk
Maternal screening modalities including history and urine toxicology identify almost all neonates who require monitoring for NOWS. NUDS did not identify additional at-risk neonates. Prospective studies are warranted to assess a balanced approach to NUDS that prioritizes newborn safety while reducing maternal stigmatization and minimizing separation.
Authors
- Dina El‐Metwally (ORCID: https://orcid.org/0000-0003-1394-6789)
- Kristina G. Witcher (ORCID: https://orcid.org/0000-0003-1832-6861)
- Katrina Mark (ORCID: https://orcid.org/0000-0001-5127-2936)
- Amy Huddleson
- Ayda Soltanian
Institutions
- University of Maryland, Baltimore (US)
Publication Details
- Journal
- PEDIATRICS
- Published
- 2025-08-12
- DOI
- https://doi.org/10.1542/peds.2024-068612
- Citations
- 2
- Primary Topic
- Prenatal Substance Exposure Effects
- Type
- article
- Field-Weighted Citation Impact
- 6.99